Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
International Royalty Corporation
International Royalty to raise C$50 million in bought deal financing
July 12th, 2009
International Royalty Corporation (NYSE-A: ROY, TSX: IRC) (the "Company" or "IRC") is pleased to announce that it has entered into an agreement with a syndicate of underwriters which has agreed to purchase, on a bought deal basis, 14,100,000 common shares of the Company ("Shares") at a price of C$3.55 per Share for aggregate proceeds of approximately C$50 million. The underwriters will also have an option, exercisable in whole or in part for a period of 30 days after closing, to purchase up to an additional 2,115,000 Shares on the same terms and conditions to cover over-allotments and for market stabilization purposes. The offering is expected to...
Source: Pharma Investments, Ventures & Law Weekly (2009-07-12)
|
